News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Jackson Scott Thomas
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2023 |
4
| Jackson Scott Thomas (Director) has filed a Form 4 on MACROGENICS INC|
Txns:
| Granted 19,000 options to buy
@ $4.67, valued at
$88.7k
Granted 4,500 restricted stock units
@ $0 |
|
| 09/19/2022 |
4
| Jackson Scott Thomas (Director) has filed a Form 4 on Spero Therapeutics, Inc.|
Txns:
| Granted 15,000 shares
@ $0 |
|
| 05/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/18/2021 |
4
| Jackson Scott Thomas (Director) has filed a Form 4 on Spero Therapeutics, Inc.|
Txns:
| Granted 7,500 options to buy
@ $13.69, valued at
$102.7k
|
|
| 05/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/27/2020 |
4
| Jackson Scott Thomas (Director) has filed a Form 4 on Spero Therapeutics, Inc.|
Txns:
| Granted 7,500 options to buy
@ $13.52, valued at
$101.4k
|
|
| 06/23/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2020 |
4
| Jackson Scott Thomas (Director) has filed a Form 4 on GLYCOMIMETICS INC|
Txns:
| Granted 21,000 options to buy
@ $3, valued at
$63k
|
|
| 05/15/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/23/2020 |
3
| Jackson Scott Thomas (Director) has filed a Form 3 on Spero Therapeutics, Inc. |
| 05/21/2019 |
4
| Jackson Scott Thomas (Director) has filed a Form 4 on GLYCOMIMETICS INC|
Txns:
| Granted 21,000 options to buy
@ $12.39, valued at
$260.2k
|
|
| 05/20/2019 |
4
| Jackson Scott Thomas (Director) has filed a Form 4 on MACROGENICS INC|
Txns:
| Granted 10,000 options to buy
@ $18, valued at
$180k
|
|
| 11/28/2018 |
4
| Jackson Scott Thomas (Director) has filed a Form 4 on GLYCOMIMETICS INC|
Txns:
| Granted 22,000 options to buy
@ $11.52, valued at
$253.4k
|
|
| 11/28/2018 |
3
| Jackson Scott Thomas (Director) has filed a Form 3 on GLYCOMIMETICS INC |
| 05/21/2018 |
4
| Jackson Scott Thomas (Director) has filed a Form 4 on MACROGENICS INC|
Txns:
| Granted 10,000 options to buy
@ $21.34, valued at
$213.4k
|
|
| 05/22/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/25/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/25/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 07/12/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/07/2016 |
4
| Jackson Scott Thomas (CEO) has filed a Form 4 on Celator Pharmaceuticals Inc|
Txns:
| Exercised 38,135 options to buy
@ $3.37, valued at
$128.5k
Exercised 117,064 options to buy
@ $2.44, valued at
$285.6k
Exercised 96,276 options to buy
@ $3.116, valued at
$300k
|
|
| 01/29/2016 |
4
| Jackson Scott Thomas (CEO) has filed a Form 4 on Celator Pharmaceuticals Inc|
Txns:
| Granted 295,000 options to buy
@ $1.32, valued at
$389.4k
Granted 118,835 options to buy
@ $1.32, valued at
$156.9k
|
|
| 10/07/2015 |
4
| Jackson Scott Thomas (CEO) has filed a Form 4 on Celator Pharmaceuticals Inc|
Txns:
| Bought 14,450 shares
@ $1.74, valued at
$25.1k
|
|
| 02/27/2015 |
4
| Jackson Scott Thomas (CEO) has filed a Form 4 on Celator Pharmaceuticals Inc|
Txns:
| Granted 22,593 shares
@ $0
Granted 175,000 options to buy
@ $2.79, valued at
$488.3k
|
|
| 11/18/2014 |
4
| Jackson Scott Thomas (CEO) has filed a Form 4 on Celator Pharmaceuticals Inc|
Txns:
| Bought 10,000 shares
@ $2.2, valued at
$22k
|
|
| 02/20/2014 |
4
| Jackson Scott Thomas (CEO) has filed a Form 4 on Celator Pharmaceuticals Inc|
Txns:
| Granted 157,000 options to buy
@ $3.22, valued at
$505.5k
|
|
| 12/17/2013 |
4
| Jackson Scott Thomas (CEO) has filed a Form 4 on Celator Pharmaceuticals Inc|
Txns:
| Bought 3,000 shares
@ $3.4968, valued at
$10.5k
|
|
| 08/27/2013 |
4
| Jackson Scott Thomas (CEO) has filed a Form 4 on Celator Pharmaceuticals Inc|
Txns:
| Granted 430,000 options to buy
@ $3.116, valued at
$1.3M
|
|
| 01/14/2013 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
|
|